Sernova Biotherapeutics Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	0.27	6.01	8.72	3.78	27.87
Short-Term Investments	-	-	11.08	46	-
Cash & Short-Term Investments	0.27	6.01	19.81	49.78	27.87
Cash Growth	-95.59%	-69.64%	-60.21%	78.57%	605.78%
Other Receivables	0.12	0.3	1.05	1.15	0.45
Receivables	0.12	0.3	1.05	1.15	0.45
Prepaid Expenses	0.14	0.16	0.16	0.17	0
Total Current Assets	0.52	6.47	21.02	51.09	28.33
Property, Plant & Equipment	0.02	0.83	0.51	0.65	0.56
Other Intangible Assets	-	-	0.32	0.52	0.72
Other Long-Term Assets	0.22	0.22	0.26	0.22	0.21
Total Assets	0.76	7.53	22.11	52.48	29.82
Accounts Payable	17.67	17.24	6.85	3.61	0.38
Accrued Expenses	3.4	2.67	2.51	0.99	0.91
Short-Term Debt	3.73	-	-	-	-
Current Portion of Leases	-	0.1	0.14	0.14	0.12
Other Current Liabilities	-	-	0.1	-	0.07
Total Current Liabilities	24.8	20.02	9.59	4.74	1.48
Long-Term Debt	1.04	-	-	-	-
Long-Term Leases	-	0.47	-	0.14	0.28
Total Liabilities	25.84	20.48	9.59	4.88	1.75
Common Stock	118.7	116.68	110.99	110.99	74.01
Additional Paid-In Capital	21.79	20.69	19.69	12.49	5.11
Retained Earnings	-166.1	-150.36	-118.17	-79.17	-54.75
Comprehensive Income & Other	0.54	0.03	-	3.3	3.69
Shareholders' Equity	-25.08	-12.96	12.51	47.61	28.07
Total Liabilities & Equity	0.76	7.53	22.11	52.48	29.82
Total Debt	4.77	0.57	0.14	0.28	0.39
Net Cash (Debt)	-4.51	5.44	19.67	49.5	27.48
Net Cash Growth	-	-72.33%	-60.26%	80.13%	746.40%
Net Cash Per Share	-0.01	0.02	0.06	0.18	0.11
Filing Date Shares Outstanding	336.7	328.48	303.33	303.33	262.26
Total Common Shares Outstanding	332.85	325.32	303.33	303.33	261.13
Working Capital	-24.27	-13.55	11.43	46.35	26.85
Book Value Per Share	-0.08	-0.04	0.04	0.16	0.11
Tangible Book Value	-25.08	-12.96	12.2	47.09	27.35
Tangible Book Value Per Share	-0.08	-0.04	0.04	0.16	0.10
Machinery	0.21	0.9	0.9	0.8	0.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.